2024
Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection
Malden D, Liu I, Qian L, Sy L, Lewin B, Asamura D, Ryan D, Bezi C, Williams J, Kaiser R, Daley M, Nelson J, McClure D, Zerbo O, Henninger M, Fuller C, Weintraub E, Saydah S, Tartof S. Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection. Nature Communications 2024, 15: 4101. PMID: 38778026, PMCID: PMC11111703, DOI: 10.1038/s41467-024-48022-9.Peer-Reviewed Original ResearchConceptsElectronic health recordsPost-COVID conditionsMatched Cohort StudyRetrospective Matched Cohort StudyRelative riskCohort studyAdjusted relative risksSARS-CoV-2 positive testAssociated with reduced riskMental health disordersPositive SARS-CoV-2 testLow riskLong-term consequences of COVID-19Health recordsSARS-CoV-2 testingPoisson regressionHealth disordersHealthcare systemCOVID-19SARS-CoV-2 infectionConsequences of COVID-19Younger ageCOVID-19 casesSARS-CoV-2Long-term consequences
2023
1368. In-hospital and post-discharge mortality among adults with COVID-19 associated hospitalization, COVID-NET, March 2020–April 2021.
Patel K, Kirley P, Kawasaki B, Meek J, Openo K, Monroe M, Henderson J, Lynfield R, Sosin D, Rowe A, Bushey S, Shiltz E, Sutton M, Talbot H, Swain A, Whitaker M, Taylor C, Havers F. 1368. In-hospital and post-discharge mortality among adults with COVID-19 associated hospitalization, COVID-NET, March 2020–April 2021. Open Forum Infectious Diseases 2023, 10: ofad500.1205. PMCID: PMC10677354, DOI: 10.1093/ofid/ofad500.1205.Peer-Reviewed Original ResearchCOVID-19-Associated Hospitalization Surveillance NetworkPost-discharge mortalityCOVID-19-associated hospitalizationLaboratory-confirmed COVID-19Hospitalization ratesHospital mortalityChart reviewAdult ageLaboratory-confirmed COVID-19-associated hospitalizationsCOVID-19Positive SARS-CoV-2 testAge groupsPopulation-based surveillance systemSARS-CoV-2 testSurveillance networkDetailed chart reviewFull chart reviewDeath certificate dataProportion of mortalityHospital dischargeCase definitionCertificate dataHospitalizationHospitalMortality473. Trends among hospitalized pregnant patients with laboratory-confirmed SARS-CoV-2 — COVID-NET, 14 U.S. States, January 2021–January 2023
Havers F, Whitaker M, Milucky J, Patton M, Chatwani B, Chai S, Armistead I, Meek J, Openo K, Weigel A, Ryan P, Nunez V, Bye E, Rudin D, Engesser K, Bushey S, Moran N, Sutton M, Talbot H, Olsen K, Taylor C. 473. Trends among hospitalized pregnant patients with laboratory-confirmed SARS-CoV-2 — COVID-NET, 14 U.S. States, January 2021–January 2023. Open Forum Infectious Diseases 2023, 10: ofad500.543. PMCID: PMC10679218, DOI: 10.1093/ofid/ofad500.543.Peer-Reviewed Original ResearchSARS-CoV-2 testPositive SARS-CoV-2 testCOVID-19-Associated Hospitalization Surveillance NetworkHospitalized pregnant patientsPregnant patientsRespiratory symptomsClinical outcomesBooster dosesCOVID-19 respiratory symptomsIntensive care unit admissionPositive SARS-CoV-2SARS-CoV-2 infectionPrimary vaccination seriesSymptomatic pregnant patientsCare unit admissionAdverse clinical outcomesSevere clinical outcomesCOVID-19 vaccinationCOVID-19 infectionSARS-CoV-2Unit admissionVaccination seriesAsymptomatic patientsChart abstractionMechanical ventilationCOVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥65 Years — COVID-NET, 13 States, January–August 2023
Taylor C, Patel K, Patton M, Reingold A, Kawasaki B, Meek J, Openo K, Ryan P, Falkowski A, Bye E, Plymesser K, Spina N, Tesini B, Moran N, Sutton M, Talbot H, George A, Havers F, Team C, Team C, Kirley P, Armistead I, Yousey-Hindes K, Oosmanally N, Monroe M, Henderson J, D’Heilly P, Hancock E, Barney G, Bushey S, Billing L, Abdullah N, Schaffner W, Mendez E. COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥65 Years — COVID-NET, 13 States, January–August 2023. MMWR Morbidity And Mortality Weekly Report 2023, 72: 1089-1094. PMID: 37796744, PMCID: PMC10564325, DOI: 10.15585/mmwr.mm7240a3.Peer-Reviewed Original ResearchConceptsCOVID-19-associated hospitalizationCOVID-19-Associated Hospitalization Surveillance NetworkCOVID-19-associated hospitalization ratesHospitalization ratesAge groupsIntensive care unit admissionMultiple underlying conditionsSevere COVID-19 diseasePromote early treatmentPositive SARS-CoV-2 testSARS-CoV-2 infectionPrevent SARS-CoV-2 infectionYounger age groupsClinical characteristicsUnit admissionUnderlying conditionEarly treatmentSARS-CoV-2 testingIncreased riskSevere COVID-19-associated outcomesSevere outcomesCOVID-19 hospitalizationElevated riskCOVID-19 diseaseBivalent vaccineOutcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO)
Tuan J, Sharma M, Kayani J, Davis M, McManus D, Topal J, Ogbuagu O. Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO). BMC Infectious Diseases 2023, 23: 258. PMID: 37101135, PMCID: PMC10130811, DOI: 10.1186/s12879-023-08198-9.Peer-Reviewed Original ResearchConceptsCOVID-19 patientsPregnant womenClinical outcomesEmergency departmentPositive SARS-CoV-2 testAdverse feto-maternal outcomesIntensive care unit admissionMild-moderate COVID-19Pregnant COVID-19 patientsPrimary composite clinical outcomeSARS-CoV-2 testComplete primary vaccinationComposite clinical outcomeCare unit admissionFeto-maternal outcomeMedical record reviewSARS-CoV-2 treatmentBetter clinical outcomesBody mass indexSickle cell diseaseCOVID-19SARS-CoV-2Neonatal complicationsPrimary vaccinationUnit admission
2022
Early Adoption of Anti–SARS-CoV-2 Pharmacotherapies Among US Veterans With Mild to Moderate COVID-19, January and February 2022
Bajema K, Wang X, Hynes D, Rowneki M, Hickok A, Cunningham F, Bohnert A, Boyko E, Iwashyna T, Maciejewski M, Viglianti E, Streja E, Yan L, Aslan M, Huang G, Ioannou G. Early Adoption of Anti–SARS-CoV-2 Pharmacotherapies Among US Veterans With Mild to Moderate COVID-19, January and February 2022. JAMA Network Open 2022, 5: e2241434. PMID: 36367727, PMCID: PMC9652752, DOI: 10.1001/jamanetworkopen.2022.41434.Peer-Reviewed Original ResearchConceptsCOVID-19 pharmacotherapySevere COVID-19SARS-CoV-2Health care systemCohort studyRisk factorsCare systemMedical conditionsCOVID-19Positive SARS-CoV-2 testVeterans Affairs Health Care SystemCOVID-19-related hospitalizationCOVID-19-related symptomsLarge integrated health care systemSARS-CoV-2 testVA health care systemIntegrated health care systemNon-Hispanic veteransModerate COVID-19Odds of receiptMultivariable logistic regressionCOVID-19 vaccinationMedical comorbiditiesMedian ageAnti-SARSComparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY
Hulme WJ, Williamson EJ, Green ACA, Bhaskaran K, McDonald HI, Rentsch CT, Schultze A, Tazare J, Curtis HJ, Walker AJ, Tomlinson LA, Palmer T, Horne EMF, MacKenna B, Morton CE, Mehrkar A, Morley J, Fisher L, Bacon SCJ, Evans D, Inglesby P, Hickman G, Davy S, Ward T, Croker R, Eggo RM, Wong AYS, Mathur R, Wing K, Forbes H, Grint DJ, Douglas IJ, Evans SJW, Smeeth L, Bates C, Cockburn J, Parry J, Hester F, Harper S, Sterne JAC, Hernán MA, Goldacre B. Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY. The BMJ 2022, 378: e068946. PMID: 35858680, PMCID: PMC9295078, DOI: 10.1136/bmj-2021-068946.Peer-Reviewed Original ResearchConceptsCovid-19 related hospital admissionCOVID-19 vaccineCOVID-19 diseaseRelated hospital admissionsCumulative incidenceHospital admissionSocial care workersCare workersCohort studyHealthcare workersPositive SARS-CoV-2 testBNT162b2 COVID-19 vaccineChAdOx1 COVID-19 vaccineSARS-CoV-2 positive testSARS-CoV-2 infectionSARS-CoV-2 alpha variantSARS-CoV-2 testCOVID-19First vaccine doseComparative effectiveness trialFirst dose vaccinationBNT162b2 mRNAHospital attendanceVaccine doseVaccine typesDescribing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY
Green A, Curtis H, Hulme W, Williamson E, McDonald H, Bhaskaran K, Rentsch C, Schultze A, MacKenna B, Mahalingasivam V, Tomlinson L, Walker A, Fisher L, Massey J, Andrews C, Hopcroft L, Morton C, Croker R, Morley J, Mehrkar A, Bacon S, Evans D, Inglesby P, Hickman G, Ward T, Davy S, Mathur R, Tazare J, Eggo R, Wing K, Wong A, Forbes H, Bates C, Cockburn J, Parry J, Hester F, Harper S, Douglas I, Evans S, Smeeth L, Goldacre B. Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY. BMC Medicine 2022, 20: 243. PMID: 35791013, PMCID: PMC9255436, DOI: 10.1186/s12916-022-02422-0.Peer-Reviewed Original ResearchConceptsPositive SARS-CoV-2 testSARS-CoV-2 testBreakthrough COVID-19Vaccine breakthroughBreakthrough casesCohort studyIncidence rateCOVID-19COVID-19-related hospital admissionsCOVID-19-related deathsVaccine breakthrough casesRetrospective cohort studyChronic kidney diseaseCritical care admissionSARS-CoV-2 variantsDeath registry dataCorresponding incidence ratesRoutine clinical dataHigh rateMedian followVaccine waningCare admissionHospital admissionSecond vaccinationSecondary careSARS-CoV-2 Testing and Positivity Among Persons With and Without HIV in 6 US Cohorts
Park LS, McGinnis KA, Gordon KS, Justice AC, Leyden W, Silverberg MJ, Skarbinski J, Jefferson C, Horberg M, Certa J, Napravnik S, Edwards JK, Westreich D, Bastarache L, Gangireddy S, Benning L, D'Souza G, Williams C, Althoff KN. SARS-CoV-2 Testing and Positivity Among Persons With and Without HIV in 6 US Cohorts. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2022, 90: 249-255. PMID: 35195574, PMCID: PMC9203911, DOI: 10.1097/qai.0000000000002943.Peer-Reviewed Original ResearchConceptsSARS-CoV-2SARS-CoV-2 testingHIV statusClinical cohortPositive SARS-CoV-2 testSARS-CoV-2 positivitySARS-CoV-2 testCOVID-19-related outcomesProportion of PWHProportion of patientsSARS-CoV-2 variantsCOVID-19 vaccineLatest therapeutic optionsTherapeutic optionsUS cohortPositivity proportionInterval cohortPWHPWOHCohortHealth systemDiverse cohortHIVPositivityTesting proportionsA multicenter evaluation of computable phenotyping approaches for SARS-CoV-2 infection and COVID-19 hospitalizations
Khera R, Mortazavi BJ, Sangha V, Warner F, Patrick Young H, Ross JS, Shah ND, Theel ES, Jenkinson WG, Knepper C, Wang K, Peaper D, Martinello RA, Brandt CA, Lin Z, Ko AI, Krumholz HM, Pollock BD, Schulz WL. A multicenter evaluation of computable phenotyping approaches for SARS-CoV-2 infection and COVID-19 hospitalizations. Npj Digital Medicine 2022, 5: 27. PMID: 35260762, PMCID: PMC8904579, DOI: 10.1038/s41746-022-00570-4.Peer-Reviewed Original ResearchCOVID-19 hospitalizationMayo ClinicDiagnosis codesCOVID-19 diagnosisPositive SARS-CoV-2 PCRYale New Haven Health SystemPositive SARS-CoV-2 testSARS-CoV-2 infectionSARS-CoV-2 PCRSARS-CoV-2 testCOVID-19Higher inhospital mortalitySARS-CoV2 infectionElectronic health record dataICD-10 diagnosisPositive laboratory testsHealth record dataInhospital mortalityAdditional patientsAntigen testSecondary diagnosisPrincipal diagnosisMulticenter evaluationPositive testComputable phenotype definitionsLegionella pneumophila and Staphylococcus aureus co-infections in a patient with SARS-CoV-2
Sanchez A, Elliott EI, Wang P, Spichler-Moffarah A. Legionella pneumophila and Staphylococcus aureus co-infections in a patient with SARS-CoV-2. BMJ Case Reports 2022, 15: e248536. PMID: 35232746, PMCID: PMC8889248, DOI: 10.1136/bcr-2021-248536.Peer-Reviewed Original ResearchConceptsCOVID-19 therapySARS-CoV-2Positive SARS-CoV-2 testSARS-CoV-2 testAcute febrile illnessCommunity-acquired pneumoniaSevere COVID-19Patient's successful recoveryCOVID-19COVID-19 managementSecond bacterial infectionMRSA pneumoniaFebrile illnessRespiratory symptomsInitial presentationHigh suspicionLobar pneumoniaWorse outcomesPositive testPatientsBacterial infectionsPneumoniaSuccessful recoveryLegionnaires' diseaseSerogroup 1
2021
Racial and Ethnic Disparities in Rates of COVID-19–Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021
Acosta AM, Garg S, Pham H, Whitaker M, Anglin O, O’Halloran A, Milucky J, Patel K, Taylor C, Wortham J, Chai SJ, Kirley PD, Alden NB, Kawasaki B, Meek J, Yousey-Hindes K, Anderson EJ, Openo KP, Weigel A, Monroe ML, Ryan P, Reeg L, Kohrman A, Lynfield R, Bye E, Torres S, Salazar-Sanchez Y, Muse A, Barney G, Bennett NM, Bushey S, Billing L, Shiltz E, Sutton M, Abdullah N, Talbot HK, Schaffner W, Ortega J, Price A, Fry AM, Hall A, Kim L, Havers FP. Racial and Ethnic Disparities in Rates of COVID-19–Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021. JAMA Network Open 2021, 4: e2130479. PMID: 34673962, PMCID: PMC8531997, DOI: 10.1001/jamanetworkopen.2021.30479.Peer-Reviewed Original ResearchConceptsCOVID-19-associated hospitalizationIntensive care unit admissionCare unit admissionSevere COVID-19Age-adjusted ratesICU admissionHospital deathUnit admissionWhite personsPacific Islander personsLaboratory-confirmed COVID-19-associated hospitalizationsAlaska NativesCOVID-19Positive SARS-CoV-2 testCOVID-19 Associated HospitalizationsEthnic disparitiesCOVID-19-Associated Hospitalization Surveillance NetworkSARS-CoV-2 testNon-Hispanic white personsIn-Hospital DeathRate ratioCross-sectional studyNon-Hispanic American IndianEthnic minority groupsNon-Hispanic blacksComprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database
Dong X, Zhou Y, Shu X, Bernstam E, Stern R, Aronoff D, Xu H, Lipworth L. Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database. Microbiology Spectrum 2021, 9: 10.1128/spectrum.00327-21. PMID: 34406805, PMCID: PMC8552669, DOI: 10.1128/spectrum.00327-21.Peer-Reviewed Original ResearchConceptsPositive SARS-CoV-2 testSARS-CoV-2 testSecond positive testElectronic health record databaseCases of reinfectionHealth record databasePositive testPositive SARS-CoV-2 PCR test resultsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testingSARS-CoV-2 PCR test resultsRecord databaseSevere acute respiratory syndrome coronavirus 2Intensive care unit admissionAcute respiratory syndrome coronavirus 2SARS-CoV-2 infectionRespiratory syndrome coronavirus 2Long-term health consequencesLarge electronic health record databasePotential long-term health consequencesCare unit admissionOverweight/obeseChronic medical conditionsPositive molecular testCOVID-19 patientsSyndrome coronavirus 2Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study
Shin Y, Shin J, Moon S, Jin H, Kim S, Yang J, Cho S, Kim S, Lee M, Park Y, Kim M, Won H, Hong S, Kronbichler A, Koyanagi A, Jacob L, Smith L, Lee K, Suh D, Lee S, Yon D. Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study. The Lancet Rheumatology 2021, 3: e698-e706. PMID: 34179832, PMCID: PMC8213376, DOI: 10.1016/s2665-9913(21)00151-x.Peer-Reviewed Original ResearchCOVID-19-related deathsGeneral health examinationAutoimmune inflammatory rheumatic diseasesCOVID-19 outcomesHealth examinationDisease-modifying antirheumatic drugsIncreased likelihoodOdds ratioInflammatory rheumatic diseasesKorean National Health Insurance ServiceNational Health Insurance ServiceDoses of systemic corticosteroidsSARS-CoV-2 RT-PCR testAdjusted odds ratiosPositive SARS-CoV-2 testHealth Insurance ServiceICD-10 codesNationwide cohort studyHealth examination recordsSystemic corticosteroidsPositive SARS-CoV-2 PCR testCOVID-19 pandemicKorean nationwide cohortRheumatic diseasesPositive SARS-CoV-2 RT-PCR testTracking smell loss to identify healthcare workers with SARS-CoV-2 infection
Weiss JJ, Attuquayefio TN, White EB, Li F, Herz RS, White TL, Campbell M, Geng B, Datta R, Wyllie AL, Grubaugh ND, Casanovas-Massana A, Muenker MC, Moore AJ, Handoko R, Iwasaki A, Martinello RA, Ko AI, Small DM, Farhadian SF, Team T. Tracking smell loss to identify healthcare workers with SARS-CoV-2 infection. PLOS ONE 2021, 16: e0248025. PMID: 33657167, PMCID: PMC7928484, DOI: 10.1371/journal.pone.0248025.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 infectionSARS-CoV-2 positive healthcare workersSmell lossHealthcare workersHome assessmentNeurological symptomsPositive SARS-CoV-2 testSARS-CoV-2 test positivitySARS-CoV-2 testPolymerase chain reaction testingReal-time quantitative polymerase chain reaction testingQuantitative polymerase chain reaction testingCOVID-19 patientsHigh-risk groupHigh-risk individualsSARS-CoV-2Self-reported changesProspective studyTest positivityAsymptomatic infectionSymptom SurveyVulnerable patientsHigh riskPositive testRisk individuals
2020
520. Longitudinal Analysis of SARS-CoV-2 Viruses in Hospitalized Adults
Simons L, Lorenzo-Redondo R, Nam H, Roberts S, Ison M, Achenbach C, Hauser A, Ozer E, Hultquist J. 520. Longitudinal Analysis of SARS-CoV-2 Viruses in Hospitalized Adults. Open Forum Infectious Diseases 2020, 7: s325-s326. PMCID: PMC7776408, DOI: 10.1093/ofid/ofaa439.714.Peer-Reviewed Original ResearchSARS-CoV-2 viral loadViral loadSARS-CoV-2Hospitalized adultsPositive SARS-CoV-2 testSARS-CoV-2 testWhole viral genome sequencingNasopharyngeal viral loadResults 60 patientsNorthwestern Memorial HospitalCoronavirus disease 2019Viral load dataSARS-CoV-2 virusImmune selective pressureViral genome sequencingQuantitative reverse transcriptase PCRReverse transcriptase-PCRNasopharyngeal specimensNasopharyngeal swabsMemorial HospitalClinical dataIndividual patientsClinical consequencesDisease 2019Immune pressure
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply